The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Ishares Msci Brazil Index Fund

NYSE: EWZ
Last

(U.S.) $36.19

Today's change0.00 0.00%
Updated January 17 8:00 PM -5GMT. Delayed by at least 15 minutes.
 

Ishares Msci Brazil Index Fund

NYSE: EWZ
Last

(U.S.) $36.19

Today's change0.00 0.00%
Updated January 17 8:00 PM -5GMT. Delayed by at least 15 minutes.

Ishares Msci Brazil Index Fund closed at (U.S.)$36.19.

Over the last five days, shares have gained 2.67% and outperformed the S&P 500 index over the last 52 weeks with a 97.38% increase in price.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $36.19
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change+8.55%
  • Volume0
  • Average volume (10-day)17,447,298
  • Average volume (1-month)17,989,621
  • Average volume (3-month)20,786,985
  • 52-week range(U.S.) $17.30 to (U.S.) $38.50
  • Beta1.34
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield1.67%
  • Trailing EPS(U.S.) -$7.20
Updated January 17 8:00 PM -5GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-382.39%

Ishares Msci Brazil Index Fund has a net profit margin of -382.39%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.25%Sector:FinancialsIndustry:Investment Trusts

Latest Company News

Latest Press Releases

    No Press Release Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q4/2014Q2/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedFeb 28, 201502/28/2015Aug 31, 201408/31/2014Feb 28, 201402/28/2014Aug 31, 201308/31/2013
Revenue7910682145
Total other revenue--------
Total revenue7910682145
Gross profit659267125
Total cost of revenue14141520
Total operating expense14141520
Selling / general / administrative--------
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income659267125
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-2,0101,30316-1,477
Income after tax-2,0101,30316-1,477
Income tax, total--000
Net income-2,0101,30316-1,477
Total adjustments to net income--------
Net income before extra. items-2,0101,30316-1,477
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-2,0101,30316-1,477
Inc. avail. to common incl. extra. items-2,0101,30316-1,477
Diluted net income-2,0101,30316-1,477
Dilution adjustment--0--0
Diluted weighted average shares10110310183
Diluted EPS excluding extraordinary itemsvalue per share-19.9112.710.16-17.75
Dividends per sharevalue per share0.420.960.590.85
Diluted normalized EPSvalue per share-19.9112.710.16-17.75